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Background: There is currently sufficient evidence available indicating that dengue and 
chikungunya viruses could be among the causes of fever in Tanzania. Overlapping clinical 
manifestations of chikungunya and dengue with other vector-borne parasitic diseases pose a 
challenge for medical diagnosis in Tanzania. A virus surveillance study was conducted in Morogoro 
Municipality which had no reports of outbreaks during high risk of transmission with dengue 












Methodology: The present study was carried out to screen for dengue (DENV) and chikungunya 
(CHIKV) in sera from patients with fever and malaria-like symptoms on selected health centres in 
Morogoro municipality (n = 5) during March-May 2018. Three hundred and twelve febrile individuals 
presenting to the outpatient department were screened for the presence of chikungunya and 
dengue viruses using Multiplex real-time reverse transcription-polymerase chain reaction. 
Results: Acute CHIKV infection was confirmed in four (1.28%) cases whereas no acute DENV 
infection was detected. Acute chikungunya cases were exclusively prevailing amongst female 
patients aged between 20 and 49 years.  
Conclusion: Our findings indicate an active circulation of chikungunya virus among febrile patients 
seeking medical attention in Morogoro Municipality, Tanzania. The improvement of CHIKV case 
detection and reporting is critical to its control and prevention. Surveillance programmes in 
monitoring arboviral activities in human populations as well as in mosquitos should be performed to 
avoid maintenance of CHIKV in mosquitoes that may lead to future outbreaks. 
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1. INTRODUCTION  
 
About 2.5 billion people (40% of the global 
population) are at risk of dengue infection, while 
50-100 million cases of the infection are 
estimated to occur each year on a global scale 
[1]. In contrary, chikungunya infection has a very 
low death rate about <0.1% in hospitalized cases 
although individuals may experience long term 
effects such as chronic inflammatory rheumatism 
which can last up to years after infection [2]. 
 
In Sub-Saharan African countries including 
Tanzania, malaria is prevalent and manifests 
similar clinical picture with other febrile illnesses 
[3,4,5]. Thus, misdiagnosis is more probable 
when these infections occur simultaneously. 
Recent studies in Tanzania have revealed that 
patients with acute dengue infection are often 
misdiagnosed and commonly given presumptive 
diagnoses of malaria, urinary tract infection and 
pneumonia [6,7]. These patients are often 
treated with anti-malaria, antibiotics and anti-
fungal drugs [8] which are largely ineffective 
against dengue and chikungunya. The 
implication of misdiagnosis and underreporting of 
arboviral diseases may result in an economic 
loss [9], development of drug-resistant malaria 
strains due to over-prescribing of antimalarials 
and risks of increased morbidity and mortality 
[10,11]. 
 
Several dengue and chikungunya outbreaks 
have been reported in Tanzania including the 
recent dengue outbreak in parts of Dar es 
Salaam (neighbouring region) in 2018 while other 
studies reported the presence of arboviruses in 
vector mosquitoes [12,13] and highly suggesting 
the underlying circulation of arboviruses in 
Tanzania. Most arboviral studies in Tanzania 
have been conducted during epidemic periods [1] 
and little is known about the virus circulation 
during the inter-epidemic period while more 
attention is given to the highly endemic regions 
leaving the non-foci regions at high risk of 
transmission. Currently, no virus surveillance 
study has been done to screen for dengue and 
chikungunya viruses as one of the underlying 
cause of fever in Morogoro municipality prior a 
dengue outbreak four years ago in Kilosa District 
and the recent outbreak in Dar es Salaam that 
kept this study area at risk of transmission. This 
study evaluated the occurrence of DENV and 
CHIKV among febrile patients visiting health 
centres in Morogoro Municipality. 
 
2. METHODOLOGY  
 
2.1 Study Area  
 
This study was conducted in Morogoro 
municipality, Tanzania. The municipality 
occupies a total of 260 square kilometers land 
coverage with a population of about 315 866 in 
2012 and is on increase [14]. The climate of the 
region is characterized by bimodal rainfall 
distribution with short rains starting from October 
to December and long rains from March to May. 
Sampling was done in urban and peri-urban 
health facilities that include Mazimbu, Mafiga, 
Sabasaba, Nunge and Sua health centers          
(Fig. 1). 
 
2.2 Study Design 
 
A cross-sectional hospital-based study was 
conducted between March and May 2018, 
enrolling individuals presenting to the outpatient 
department with the febrile condition (fever ≥ 38° 
C). A total of 312 individuals were enrolled based
 
Fig. 1. Map of Morogoro municipality indicating the five Health centres of this stud
 
on eligibility criteria and attendance ratio at each 
of the health centres until the desired sample 
size was attained. Individuals with chronic and 
debilitating illnesses were excluded from this 
study. 
 
2.3 Blood Sample Collection 
Processing 
 
Samples from peripheral venous blood (up to 4 
ml) were drawn into plain or EDTA anticoagulant 
tubes at the time of enrollment as per the 
attached standard operating procedure. Each 
plain and EDTA tube was labelled with patient 
biodata. All samples were col
centrifuged on-site to obtain serum/plasma and 
furthermore aliquoted into Cryo-vials (2 ml each) 
and later transported in the cold chain to the 
laboratory of the National Institute for Medical 




(indicated by orange colour) 
and 
lected and 
Research (NIMR) in Morogoro. At the laboratory, 
these samples were barcoded 




Stored serum and plasma were subjected to an 
in vitro automated diagnostic system a one
multiplex RT-PCR by using AccuPower® RT
PCR kit (Bioneer, Seoul, Republic 
Korea) following manufacturer’s instructions. The 
premix contained specific primers and probe for 
chikungunya and dengue RNA viruses. It 
comprises a strip of eight tubes with all 
components required for cDNA synthesis and 
PCR, such as M-MLV RT, ribonuclease (RNase) 
inhibitor, thermostable DNA polymerase, and 
deoxyribonucleotide triphosphates. The freeze


























enzymes for long periods, even beyond typical 
storage limits. 
 
The premix contained optimal concentrations of 
all the components necessary for cDNA 
synthesis and amplification in a single 0.2 ml 
tube. The primer mix was prepared by mixing 
400 nM of forwarding conserved primer (Dcon) 
and 200 nM of each reversed primer with the 
appropriate volume of DEPC-treated distilled 
water. The lyophilized pellet in the tube was 
dissolved by vortexing, followed by a brief spin. 
Briefly, 400 µL of NTC (Non-template control) 
was added into both PC (positive control) and 
NC (negative control) sample loading tubes, 7µL 
of PC were added into the PC sample loading 
tubes and 400 µL of blood serum were added to 
the remaining sample loading tubes. This 
includes, 14 blood serum sample loading tubes, 
1NTC loading tube and 1PC loading tubes (A 
total of 16 loading tubes) were placed in one 
ExiPrep for RNA extraction. A 30 minutes RT-
PCR step was performed at 50°C followed by a 
15 min Taq polymerase activation at 95°C, 40 
cycles of PCR denaturation at 95°C for the 30s, 
60°C of annealing for 30s and 72°C extension for 
1 min. RT-PCR was performed in a Master cycler 
gradient machine (Eppendorf, Hamburg, 
Germany) for 2½ hours. The use of AccuPower 
RT-PCR premix had greatly facilitated the 
diagnosis work. Since every single tube contains 
all the essential components for the RT-PCR 
premix and fewer steps were required in the 
protocol which helped to reduce not only 
potential errors but also the time needed to 
prepare the assays as well as risks of cross-
contamination. 
 
2.5 Data Analysis 
 
Data collected in this study were entered and 
analyzed using Microsoft Office-Excel 2016 
(Microsoft, California, USA) for cleaning and 
descriptive statistics. The demographic 
backgrounds including, age, sex, and locality 
were analyzed. Multiplex real-time RT-PCR data 
analysis was performed by calculating the 
threshold cycle (CT) value represented by the 
positive amplification of the gene in the RT cycle 
numeral. 
 
3. RESULTS  
 
3.1 Demographic Profiles of the Enrolled 
Outpatients 
 
There were 312 febrile individuals enrolled in the 
study whereas a high number of participants 
were young adults 125 (40%) aged between 20 
and 29 years. The majority of enrollments were 
from Mazimbu hospital (42%) followed by Nunge 
(21%), Mafiga (14%), Sabasaba (12%) and SUA 
(12%) health centres, respectively. Out of these 
study participants, 230 (74%) were females and 
82 (26%) were males (Table 1).     
 
3.2 Screening of Dengue and 
Chikungunya Viruses 
 
Out of 312 serum and plasma samples tested by 
multiplex real-time RT-PCR, only four (4) febrile
 
Table 1. Prevalence of DENV AND CHIKV infections among febrile outpatients and their social 
demographic characteristics between March and May 2018, in Morogoro municipality, 
Tanzania 
 
Variables  Level Frequency n (col %) DENV % (nα /N) CHIKV % (nα/N)  
Gender Male 82 (26%) - _ 
Female 230 (74%) - 1.7% (4/230) 
Age (in years) 0-9 17 (6%) - - 
10 -19 48 (15%) - - 
20-29 125 (40%) - 1.6% (2/125) 
30-39 60 (19%) - 1.7% (1/60) 
40-49 29 (9%) - 3.4% (1/29) 
>50 33 (11%) - - 
Hospital/Health 
care centres 
Mazimbu  130 (42%) - 1.5% (2/130) 
Mafiga  43 (14%) - - 
Nunge 64 (21%) - 1.6% (1/64) 
Sabasaba  38 (12%) - - 
SUA 37 (12%) - 2.7% (1/37) 
* n= number of participants; n
α
= number of positive patients; N= total number of participants tested in each 
variable level; SUA – Sokoine University of Agriculture 
patients (1.28%) confirmed acute CHIKV 
infection. However, none of the 312 participants 
had confirmed acute DENV infection (Fig. 2). 
Dengue and chikungunya cases were classified
according to WHO [15] criteria. Thus, the acute 
chikungunya case definition was confirmed by 
positive PCR results. Chikungunya cases were 
exclusively prevailing amongst females febrile 





Monitoring arbovirus infections as part of 
virological surveillance in humans including virus 
isolation from human serum and mosquito 
inoculations has greatly influenced outbreak 
predictions globally [16]. The study has 
demonstrated the presence of CHIKV infection in 
febrile patients seeking medical care in health 
facilities during the non-epidemic period. In 
 
 
Fig. 2. a; The amplification plot of multiplex real
represents a specific virus, Green
amplification plot of Multiplex real
(CHIKV & DENV) negative samples. c; The amplification plot of Multiplex Real
positive CHIKV showing the internal positive control and CHIKV positive samples as the






malaria-endemic areas, most febrile illnesses 
have been and are treated as malaria cases due 
to lack of diagnostic capacity [3,4,10,
attributed by the similar clinical picture in the 
initial stage of illness of dengue, chikungunya 
and other febrile illnesses. The diagnostic 
capacity to rule-out chikungunya, dengue and 
other infections has remained an obstacle to t
control and prevention in resource
settings [12]. 
 
This study has revealed 1.3% of CHIKV 
occurrence and suggesting active CHIKV 
transmission in Morogoro Municipal. This 
prevalence is less than the previously reported 
chikungunya prevalence in different regions of 
the country [6,17,18,19]. The variation in many 
studies may be endorsed by the time factor, 
seasonal variations and climatic changes [8]. 
Furthermore, CHIKV infection symptoms last for 
about 2-10 days, the time in w
-time RT-PCR results, where each colour 
- DENV, Blue-IPC, Red- CHIKV, and Brown- ZIKV. b; the 
-time RT-PCR showing the internal positive control and 
-time RT


























Table 2.  Ct values for positive chikungunya virus samples 
 
Sample ID CHIKV CT DENV CT 
IPC 28.49 28.14 
29 27.2 - 
128 32.01 - 
146 35.08 - 
197 30.04 - 
 
present in the blood circulation and it can be 
detected by PCR only within this limit. The 
sensitivity of acute infection diagnosis after the 
viremic phase becomes minimal as virus levels 
are reduced significantly [18]. 
 
In this study, chikungunya cases were 
exclusively present in adult females ranging from 
20-49 years of age. Similarly, other studies 
reported adulthoods as a potential risk factor to 
DENV and CHIKV infections [5,20].  
 
These findings differ from a study conducted in 
Magugu district [17] which reported that male sex 
had five times higher odds of being CHIKV 
positive. Other studies have demonstrated that 
age and sex are proxy behaviour that causes 
higher exposure to mosquito bites [21,22]. Most 
adults aged between 18 and 55 years practices a 
lifestyle of staying outdoors during dusk and 
dawn hours which favours Aedes mosquito bites. 
Consequently, such exposure to mosquito bites 
propensity makes them vulnerable to mosquito-
borne diseases including dengue and 
chikungunya [23]. However, cultural dynamics in 
Tanzania where females are mostly responsible 
for farming, housekeeping, cooking, fetching 
water and firewoods, among other risk factors 
such as reduced body immunity in lactating and 
pregnant mother, these exacerbate exposure 
and development of the disease. Also, employed 
individuals and livestock keepers who are 
associated with daily movements from home to 
work have an increased chance of contracting 
Aedes mosquito bites at early morning and dusk 
from different locations [24].  
 
This study has shown that there were no DENV 
cases at the selected health centres despite its 
serological evidence in Morogoro [6] and other 
regions of the country [17,18,21]. Most of dengue 
and chikungunya studies reported in Tanzania 
were conducted during an outbreak.  
 
The absence of DENV in the collected samples 
could be due to the low rate of DENV circulation 




Febrile patients visiting health centres in 
Tanzania are routinely misdiagnosed and treated 
as malaria infection. Our findings show that 
CHIKV is an important cause of fever during the 
inter-epidemic period. Screening and 
engrossment of a differential diagnosis for 
arboviral infections and neglected tropical 
diseases is crucial to improve case management 
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